Bayer Healthcare settles aspirin marketing lawsuit for $15 million

  • Thu, 07/12/2012 - 12:32pm

A Bayer AG unit will pay $15 million to resolve a U.S. lawsuit regarding illegally marketed aspirin that contained supplements.

FDA gives Bayer’s colon cancer drug “priority”

  • Thu, 06/28/2012 - 2:29pm

The U.S. Food and Drug Administration accepted Bayer’s experimental drug regorafenib for priority review, which could make it marketable in a matter of six months.